Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
about
Routine blood cultures in the management of pyelonephritis in pregnancy for improving outcomesRoutine blood cultures in the management of pyelonephritis in pregnancy for improving outcomesAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Population-based epidemiology and microbiology of community-onset bloodstream infectionsImpact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study.Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study.Bacteremia complicating gram-negative urinary tract infections: a population-based study.A focus on intra-abdominal infections.Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolatesPreventing surgical site infections after bariatric surgery: value of perioperative antibiotic regimens.Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-20072013 WSES guidelines for management of intra-abdominal infections.Neonatal infectious diseases: evaluation of neonatal sepsis.Clinical characteristics of bloodstream infections due to ampicillin-sulbactam-resistant, non-extended- spectrum-beta-lactamase-producing Escherichia coli and the role of TEM-1 hyperproduction.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Trends in hospitalizations with antibiotic-resistant infections: U.S., 1997-2006Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infectionInfluence of referral bias on the clinical characteristics of patients with Gram-negative bloodstream infectionAntibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsyIncidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota.Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.Asthma and risk of non-respiratory tract infection: a population-based case-control study.Trends in antibiotic resistance in coagulase-negative staphylococci in the United States, 1999 to 2012Current concept of abdominal sepsis: WSES position paper.Management of complicated urinary tract infections in the era of antimicrobial resistance.Prevention and treatment of biopsy-related complications.Reducing infection rates after prostate biopsy.Change in the risk stratification of prostate cancer after Slide Review by a uropathologist: the experience of a reference center for the treatment of prostate cancer.Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.Group B streptococcal infections in the newborn infant and the potential value of maternal vaccination.Optimizing safety and accuracy of prostate biopsy.Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada.Identification of a novel sequence type of Escherichia coli as the causative agent of pyelonephritis and bloodstream infection.Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract InfectionsPopulation-Based Study of Incidence and Antimicrobial Resistance Patterns of Extraintestinal Escherichia coli Infections in Children in Olmsted County, Minnesota, 2012.The state of TRUS biopsy sepsis: readmissions to Victorian hospitals with TRUS biopsy-related infection over 5 years.Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate.Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence.Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
P2860
Q24188142-D8E13D7E-9796-483C-9A74-143441819C63Q24236022-0C939379-0934-4FB8-B34D-BA1AE90554F0Q26739860-F57E2078-4E51-49EC-BF6E-54A5599B7B34Q27013639-F20A4A10-E511-4272-A71F-A971AB6B6E07Q31102336-46E5209D-F903-40F6-ACC7-7CD88E6C9404Q33620388-D9DC695E-5332-4263-864E-1967990DF933Q33738237-D22D029E-EA8E-4568-A4D1-7753ACF9B858Q33763449-F9D28EC7-C3E1-43A9-A5D0-C985A43A0FADQ33769703-C207BF7D-0D24-4D69-A898-131313E4E78DQ33995500-B4942B99-72DA-4CEE-B5A2-546645D17562Q34007433-2E2D3753-8975-40FA-B7EE-CAA7AA1A8965Q34274088-45D9870C-D0D7-425C-8750-7DE565D77083Q34321150-69AA4EF0-5C61-4631-8B54-9BE2C4FCF86DQ34332344-3F2B29B9-E2E1-4931-96A7-52368D6881E7Q34529235-CB6D9532-1051-497B-9327-F5E6239EBD29Q34541183-3277DBD8-0562-43A0-87DE-B40202592F9FQ34773922-9966D637-D804-472C-8A9F-090EB22A6173Q35067216-226EC619-37E4-4A7F-BFA6-A692FF4E141FQ35074571-0F72D39F-A9C3-4F2E-8224-FC27DBBF8C0AQ35715463-BD9DD253-CAF4-4AAF-8961-CC5181B10FCCQ36513085-D10020C9-A9E5-4A4B-94C9-C0C3FA6391E0Q36729974-1A02BEB0-315F-476B-B8FF-9A592F612E18Q37228984-DEE893EB-5BE9-4D63-9635-8E65EC1EF03FQ37643589-D26048A3-C279-46F8-8874-8622E42DC231Q37702912-8B9B62E8-E6A8-441D-9CDF-7604CF2AB845Q37810405-55381755-E0DD-4FF4-8B04-F51449BBE8D3Q38175326-DAFB1175-13F2-4AB4-8510-88142CBA1976Q38178006-2B48C679-2102-4958-9EBF-6C9297EBDEE9Q38253942-3BAACE5F-A41B-4185-9ED4-B2255122A2DBQ38391440-95C08968-53A6-424E-BEA9-0BAE9C68624FQ38570903-0AA83914-66ED-4706-94FF-D5C39BA2FA89Q38841864-7ED81A28-6398-4D5B-B997-D1E568091BD1Q39640905-46E4852F-FEE5-459F-9F1C-ECCF383C5FD3Q40276070-78C5BFD0-B961-4D21-99D1-FCE42FC09900Q40334475-3D8EEAF2-1590-4076-BED3-903DA3A8D1FCQ40624736-BD3818C5-77CD-4A4D-8900-C8B9B0C92FC4Q40734494-83E54DC8-C391-4DB9-A51E-87A535CE9A6BQ46952477-14446EE6-1A8A-4713-8476-187BBFDD0342Q49587319-A9E0623A-962D-4306-9751-ED9C903740EDQ54205988-30E20ED2-A2DD-4B5D-AA43-48BA57777FB0
P2860
Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@en
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@nl
type
label
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@en
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@nl
prefLabel
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@en
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@nl
P2093
P2860
P356
P1476
Antimicrobial resistance trend ...... lation-based study, 1998-2007.
@en
P2093
Brian D Lahr
Jeanette E Eckel-Passow
Larry M Baddour
Majdi N Al-Hasan
P2860
P304
P356
10.1093/JAC/DKP162
P407
P577
2009-05-12T00:00:00Z